Top Markets
#1 MowCat MowCat +48.88%
#2 Audiera Audiera +27.80%
#3 Bermuda Shorts Bermuda Shorts +24.76%
#4 Biconomy Biconomy +22.49%
#5 Velvet Velvet +22.49%
#6 aPriori aPriori +20.85%
#7 Derive Derive +19.60%
#8 Quack AI Quack AI +18.95%
#9 SkyAI SkyAI +14.21%
#10 Geodnet Geodnet +12.09%
Coin of the day
MowCat MowCat
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
Pozycja w akcjach #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
Cena akcji
$1.85
Ostatnia synchronizacja: 2024-08-19
Kapitalizacja rynkowa
$3.96M
Zmiana (1 dzień)
2.78%
Zmiana (1 rok)
0.00%
Kraj
US
Handel MyMD Pharmaceuticals, Inc. (MYMD)

Kategoria

Healthcare
Historia ceny akcji dla MyMD Pharmaceuticals, Inc. (MYMD)
Najwyższa cena zamknięcia: $1.83 dnia 2024-08-01

Najniższa cena zamknięcia: $120.01K dnia 2014-01-01
Historia cen akcji firmy MyMD Pharmaceuticals, Inc. od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 -76.01%
2023 -82.01%
2022 -78.21%
2021 60.05%
2020 -42.41%
2019 -86.46%
2018 -78.63%
2017 -81.85%
2016 23.71%
2015 -54.94%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE